Mode
Text Size
Log in / Sign up
N/A N=91 Randomized Single-blind Treatment

Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS

Traumatic Brain Injury · Post-Traumatic Stress Disorder

Enrolled (actual)
91
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Change From Baseline in Community Reintegration for Injured Service Members at 2 Months — 40.22; 37.79 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Experimental - COMPASS (Behavioral); Control - COMPASS (Behavioral)
Age
Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Mar 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline in Community Reintegration for Injured Service Members at 2 Months
40.22; 37.79
PRIMARY
Change From Baseline in Frontal Systems Behavior Scale at 2 Months
85.4; 84.3

Summary

Interventional, controlled clinical trial with two arms, 110 Veterans with TBI and PTSD

Eligibility Criteria

Inclusion Criteria

  • TBI of at least mild severity using criteria related to disturbance of consciousness (VHA TBI Comprehensive Evaluation screening tool).
  • Obtained informed consent.
  • Males or females of working age, between the ages of 18 and 55.
  • Medically stable with physician approval to participate
  • Ability to comprehend and communicate in English at a 6th grade level
  • Executive dysfunction as identified by Frontal Systems Rating Scale (FrSBe) and/or other study assessments

Exclusion Criteria

  • Unable to provide informed consent and no proxy available.
  • Severe impairment of language or day- to-day memory that would preclude participation in a verbally-based therapy.
  • Life expectancy of less than 36 months.
  • Severe multiple trauma (as judged by the attending physicians and/or investigators that is too severe to participate in this study) such as:
  • severe burns
  • serious organ damage
  • amputations
  • multiple fractures
  • History of substance abuse severe enough to cause neurologic damage, pre-morbid history of neurologic disease (e.g., stroke).
  • Prior history of known bipolar disorder or schizophrenia or severe psychiatric illness as determined by medical history.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01816061). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search